Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice

Journal of Clinical Investigation

Volumn 101, Issue 2, 1998, Pages 364-371

  Balomenos, Dimitrios ^a   Rumold, Robert ^a   Theofilopoulos, Argyrios N ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Immunology Department/IMM3   (United States)

Author keywords

IFN ; Lupus; MRL lpr

Indexed keywords

BROXURIDINE; CYTOKINE; DNA ANTIBODY; DOUBLE STRANDED DNA; FAS ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; GENE DISRUPTION; GLOMERULONEPHRITIS; HYPERGAMMAGLOBULINEMIA; IMMUNE COMPLEX DEPOSITION; KIDNEY PROXIMAL TUBULE; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0032518439     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI750     Document Type: Article

References (43)

1. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.
2. O'Garra, A., and K. Murphy. 1993. T-cell subsets in autoimmunity. Curr. Opin. Immunol. 5:880-886.
3. Theofilopoulos, A.N. 1992. Murine models of SLE. In Systemic Lupus Erythematosus. R.G. Lahita, editor. Churchill-Livingstone, Inc. New York. 121-194.
4. Prud'homme, G.J. 1993. Cytokines and Autoimmunity. In Molecular Pathology of Autoimmunity. C.A. Bona, K. Siminovitch, M. Zanetti, and A.N. Theofilopoulos, editors. Harwood Academic Publishers, Langhorne, PA. 149-167.
5. Murray, L.J., R. Lee, and C. Martens. 1990. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 20:163-170.
6. Prud'homme, G.J., D.H. Kono, and A.N. Theofilopoulos. 1995. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β interleukin-10, and interferon-gamma mRNA in the lymph nodes of lupus-prone mice. Mol. Immunol. 32:495-503.
7. Jacob, C.O., P.H. van der Meide, and H.O. McDevitt. 1987. In vivo treatment of (NZBxNZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J. Exp. Med. 166:798-803.
8. Ozmen, L., D. Roman, M. Fountoulakis, G. Schmid, B. Ryffel, and G. Garotta. 1995. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur. J. Immunol. 25:6-12.
9. Takahashi, S., L. Fossati, M. Iwamoto, R. Merino, R. Motta, T. Kobayakawa, and S. Izui. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97:1597-1604.
10. Trinchieri, G., and F. Gerosa. 1996. Immunoregulation by interleukin-12. J. Leukocyte Biol. 59:505-511.
11. Huang, F.-P., G.-J. Feng, G. Lindop, D.I. Stott, and F.Y. Liew. 1996. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J. Exp. Med. 183:1447-1459.
12. Nicoletti, F., P. Meroni, R. DiMarco, W. Barcellini, M.O. Borghi, M. Gariglio, A. Mattina, S. Grasso, and S. Landolfo. 1992. In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse. Immunopharmacology. 24:11-16.
13. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1739-1742.
14. Andrews, B.S., R.S. Eisenberg, A.N. Theofilopoulos, S. Izui, C.B. Wilson, P.J. McConahey, E.D. Murphy, J.B. Roths, and F.J. Dixon. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1198-1215.
15. Burlingame, R., R.L. Rubin, R.S. Balderas, and A.N. Theofilopoulos. 1993. The genesis and evolution of anti-chromatin autoantibodies in murine lupus implicates T-dependent immunization with self-antigen. J. Clin. Invest. 91: 1687-1696.
16. Tough, D.F., and J. Sprent. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127-1135.
17. Izui, S., V.E. Kelley, K. Masuda, H. Yoshida, J.B. Roths, and E.D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227-233.
18. fyn in their activation and expansion. J. Immunol. 159:2265-2273.
19. Young, H.A., and K.J. Hardy. 1995. Role of interferon-gamma in immune cell regulation. J. Leukocyte Biol. 58:373-381.
20. Kofler, R., R.D. Schreiber, F.J. Dixon, and A.N. Theofilopoulos. 1984. Macrophage Ia expression, production of, and response to, macrophage-stimulating lymphokines in murine lupus strains. Cell. Immunol. 87:92-100.
21. Kelley, V.E. and J.B. Roths. 1982. Increase in macrophage Ia expression in autoimmune mice: role of the lpr gene. J. Immunol. 129:923-925.
22. Lu, C.Y. and E.R. Unanue. 1982. Spontaneous T-cell lymphokine production and enhanced macrophage Ia expression and tumoricidal activity in MRL-lpr mice. Clin. Immunol. Immunopathol. 25:213-222.
23. Wuthrich, R.P., M.A. Yui, G. Mazoujian, N. Nabavi, L.H. Glimcher, and V.E. Kelley. 1989. Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis. Am. J. Pathol. 134:45-51.
24. Altman, A., A.N. Theofilopoulos, R. Weiner, D.H. Katz, and F.J. Dixon. 1981. Analysis of T cell function in autoimmune murine strains. Defects in production of, and responsiveness to, interleukin 2. J. Exp. Med. 154:791-909.
25. Wofsy, D., E.D. Murphy, J.B. Roths, M.J. Dauphinee, S.B. Kipper, and N. Talal. 1981. Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice hearing the lpr gene. J. Exp. Med. 154:1671-1680.
26. Prud'homme, G.J., C.H. Park, T. Fieser, R. Kofler, F.J. Dixon, and A.N. Theofilopoulos. 1983. Identification of a B-cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of lpr/lpr genotype. J. Exp. Med. 157:730-742.
27. Murray, L., and C. Martens. 1989. The abnormal T lymphocytes in lpr mice transcribe interferon-gamma and tumor necrosis factor-alpha genes spontaneously in vivo. Eur. J. Immunol. 19:563-565.
28. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
29. von Herrath, M.G., and M.B.A. Oldstone. 1997. Interferon-gamma is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185:531-539.
30. Mohan, C., S. Adams, V. Stanik, and S.K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367-1381.
31. Kaliyaperumal, A., C. Mohan, W. Wu, and S.K. Datta. 1997. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183:2459-2469.
32. Pearson, C.I., W. Van Ewijk, and H.O. McDevitt. 1997. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J. Exp. Med. 185:583-599.
33. Giese, T., and W.F. Davidson. 1994. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double-negative T cells but not autoantibody production. J. Immunol. 152:2000-2010.
34. Maldonado, M.A., R.A. Eisenberg, E. Roper, P.L. Cohen, and B.L. Kotzin. 1995. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J. Exp. Med. 181:641-649.
35. Balasa, B., C. Deng, J. Lee, L.M. Bradley, D.K. Dalton, P. Christados, and N. Sarvetnick. 1997. Interferon gamma (IFN-gamma) is necessary for the genes of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J. Exp. Med. 186:385-391.
36. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1742-1745.
37. G-monomethyl-L-arginine. J. Exp. Med. 179: 651-660.
38. Peng, S.L., J. Moslehi, and J. Craft. 1997. Roles of interferon-gamma and interleukin-4 in murine lupus. J. Clin. Invest. 99:1936-1946.
39. Haas, C., B. Ryftel, and M. LeHir. 1997. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J. Immunol. 158: 5484-5491.
40. Jacob, C.O., and H.O. McDevitt. 1988. Tumor necrosis factor alpha in murine autoimmune "lupus" nephritis. Nature. 331:356-358.
41. 1 mice. J. Exp. Med. 179:305-310.
42. Santiago, M.-L., L. Fossati, C. Jacquet, W. Muller, S. Izui, and L. Reininger. 1997. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J. Exp. Med. 185:65-70.
43. 1 mice. J. Immunol. 158:1466-1472.